Microfluidic Chip Extraction With Magnetic Bead Pathogen Readout
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Wastewater-based epidemiology (WBE) in low-resource settings is hindered by the lack of infrastructure, limited technical capacity, and the need for trained personnel, with challenges including nucleic acid degradation during storage, low concentrations due to dilution, and complex concentration and identification methods requiring expensive equipment and long processing times.
Innovation Solution
A microfluidic chip system using immiscible filtration assisted by surface tension (IFAST) for nucleic acid extraction and colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) for pathogen detection, combined with a microfluidic chip reading instrument for simplified reading, enabling easy implementation in low-resource settings.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If common concentration methods (polyethylene glycol precipitation, ultrafiltration, ultracentrifugation) are used, then nucleic acid concentration is improved, but processing time increases (>90 mins) and equipment cost increases
Solution Approach 1:
The patent extracts only the essential function of concentration by using a simple filtration membrane that physically separates concentrated nucleic acid-containing droplets from diluted wastewater, eliminating the need for complex precipitation or ultracentrifugation processes while achieving rapid concentration in minutes rather than hours
Solution Approach 2:
The patent replaces complex mechanical concentration systems (ultracentrifugation machines, vacuum pumps) with a passive filtration system driven by surface tension and capillary forces, substituting expensive mechanical equipment with simple physical principles that require no external power or complex machinery
2Measurement precision
If solid-phase extraction and magnetic bead-based extraction are used, then nucleic acid extraction efficiency is improved, but cost and complexity increase and trained staff are required
Solution Approach 1:
The patent employs a porous filtration membrane with specific pore sizes that physically trap nucleic acid-containing droplets while allowing wastewater to pass through. This simple porous structure replaces complex magnetic beads and solid-phase extraction cartridges, achieving efficient nucleic acid concentration without requiring specialized materials or trained操作人员
Solution Approach 2:
The filtration system operates autonomously using inherent physical principles (surface tension, capillary action, gravity) to separate and concentrate nucleic acids without requiring external equipment, power sources, or skilled intervention. The system self-regulates the concentration process through the membrane's physical properties alone
3Measurement precision
If PCR method is used for identification, then pathogen identification accuracy is improved, but processing time increases (>1 hour) and expensive equipment is required
Solution Approach 1:
The patent changes the operational parameters of nucleic acid amplification by using isothermal conditions (constant temperature) instead of cyclic thermal changes required by PCR. This parameter change enables continuous amplification without repeated heating and cooling cycles, reducing identification time from over an hour to approximately 30 minutes while maintaining accuracy through optimized isothermal enzyme reactions
4Stability of the object's composition
If cold chain storage is used for wastewater samples, then nucleic acid stability is improved, but infrastructure requirements increase and cost increases
Solution Approach 1:
The patent performs preliminary concentration and extraction of nucleic acids from wastewater samples at the point of collection, stabilizing the nucleic acids in a concentrated form that is less susceptible to degradation. This preliminary action eliminates the need for subsequent cold chain storage and transportation, as the concentrated nucleic acid extract can be stored at higher temperatures without significant degradation
Solution Approach 2:
The patent converts the typically harmful effect of room temperature storage (which causes nucleic acid degradation in diluted wastewater) into a benefit by first concentrating the nucleic acids, which then become stable at higher temperatures. The concentration process itself protects the nucleic acids from environmental degradation factors
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system provides a cost-effective and efficient concentration, extraction, and identification workflow suitable for WBE in low-resource settings, reducing the need for specialized equipment and trained personnel, and enabling rapid pathogen detection.
Implementation Method 1
a microfluidic chip system using immiscible filtration assisted by surface tension (IFAST) for nucleic acid extraction
Implementation Method 2
a plurality of paramagnetic particles adapted to bind to a nucleic acid fraction of a targeted biological pathogen
Implementation Method 3
a magnet and actuator adapted to displace the plurality of paramagnetic particles from the biological sample well through the first isolation buffer well, the wash well, and the second isolation buffer to the elution well
Implementation Method 4
a heating element adapted to heat amplification reagents and the plurality of paramagnetic particles in the elution well
Data Source
AI summary
A concentration, extraction and identification system (CEIS) for microbiological analysis of a biological sample, includes: (1) a plurality of paramagnetic particles adapted to bind to a nucleic acid fraction of a targeted biological pathogen, (2) a microfluidic chip including a plurality of interconnected wells; and (3) a microfluidic chip reading instrument including a housing carrying (a) a microfluidic chip receiver adapted to hold the microfluidic chip and (b) a magnet and actuator adapted to displace the plurality of paramagnetic particles from a biological sample well through a first isolation buffer well, a wash well, and a second isolation buffer well to an elution well.